|
|
Regel 6: |
Regel 6: |
| == Overzicht van scenario's voor sturend/beschikbaarstellend systeem == | | == Overzicht van scenario's voor sturend/beschikbaarstellend systeem == |
| | | |
− | === Scenarioset 0===
| |
− | <section begin=overview-MGB-0 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Screenshots?|| Beschrijving
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |0.1|| || Alle medicatieafspraken van de patiënt, zonder aanvullend filtercriterium<br/>(Antwoord: bericht met 6 medicatieafspraken)
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |0.2|| || Specifieke medicatieafspraak met identificaties als filter (in kwalificatiesimulator het id van "MBH_300_QA1_MA" invoeren)<br/>(Antwoord: bericht met 1 medicatieafspraak)
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |0.3 optioneel|| || Medicatieafspraken met een filter op productcode (PRK 3956)<br/>(Antwoord: bericht met 1 medicatieafspraak)
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |0.4|| || Medicatieafspraken met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-21)<br/>(Antwoord: bericht met 4 medicatieafspraken)
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |0.5|| || Medicatieafspraken met een filter op gebruiksperiode – einddatum (alles voor T-22)<br/>(Antwoord: bericht met 3 medicatieafspraken)
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |0.6|| || Medicatieafspraken met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7)<br/>(Antwoord: bericht met 3 medicatieafspraken)
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |0.7|| || Medicatieafspraken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_300_QA1" invoeren)<br/>(Antwoord: bericht met 1 medicatieafspraak)
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |0.8|| || Een antwoord zonder medicatieafspraken (filter op gebruiksperiode – einddatum (alles voor T-110))<br/>(Antwoord: bericht zonder medicatieafspraken)
| |
− | |}
| |
− | <section end=overview-MGB-0 />
| |
| === Scenarioset 1=== | | === Scenarioset 1=== |
| <section begin=overview-MGB-1 /> | | <section begin=overview-MGB-1 /> |
Regel 154: |
Regel 131: |
| == Overzicht van scenario's voor ontvangend/raadplegend systeem == | | == Overzicht van scenario's voor ontvangend/raadplegend systeem == |
| | | |
− | === Scenarioset 0===
| + | |
− | <section begin=overview-MGR-0 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Beschrijving
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |0.1|| Alle medicatieafspraken van de patiënt, zonder aanvullend filtercriterium<br/>(Antwoord: bericht met 6 medicatieafspraken)
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |0.2|| Specifieke medicatieafspraak met identificaties als filter (in kwalificatiesimulator het id van "MBH_300_QA1_MA" invoeren)<br/>(Antwoord: bericht met 1 medicatieafspraak)
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |0.3|| Medicatieafspraken met een filter op productcode (PRK 3956)<br/>(Antwoord: bericht met 1 medicatieafspraak)
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |0.4|| Medicatieafspraken met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-21)<br/>(Antwoord: bericht met 4 medicatieafspraken)
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |0.5|| Medicatieafspraken met een filter op gebruiksperiode – einddatum (alles voor T-22)<br/>(Antwoord: bericht met 3 medicatieafspraken)
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |0.6|| Medicatieafspraken met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7)<br/>(Antwoord: bericht met 3 medicatieafspraken)
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |0.7|| Medicatieafspraken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_300_QA1" invoeren)<br/>(Antwoord: bericht met 1 medicatieafspraak)
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |0.8|| Een antwoord zonder medicatieafspraken (filter op gebruiksperiode – einddatum (alles voor T-110))<br/>(Antwoord: bericht zonder medicatieafspraken)
| |
− | |}
| |
− | <section end=overview-MGR-0 />
| |
| === Scenarioset 1=== | | === Scenarioset 1=== |
| <section begin=overview-MGR-1 /> | | <section begin=overview-MGR-1 /> |
Regel 300: |
Regel 255: |
| |} | | |} |
| <section end=overview-MGR-10 /> | | <section end=overview-MGR-10 /> |
− | == TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)==
| |
− | <section begin=mg-mp-mg-tst-MA-Scenarioset0-v30-0-1 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset0-v30-0-1 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|B.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Blik
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999900389 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|13 okt 1963
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
| |
− | |}<section end=patient-mg-mp-mg-tst-MA-Scenarioset0-v30-0-1 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v30-0-1 />
| |
− | ==== Scenario 0.1 - MBH_300_QA1====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA1_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 20 dagen om 08:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 20 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 9 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|2 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Scenario 0.1 - MBH_300_QA2====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA2_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 100 dagen om 08:04 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 100 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T - 72 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 10 ml
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Scenario 0.1 - MBH_300_QA3====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA3_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 50 dagen om 08:10 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 50 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T - 11 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|2 maal per dag 50 ml
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Scenario 0.1 - MBH_300_QA4====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA4_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 10 dagen om 08:12 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 10 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 19 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Scenario 0.1 - MBH_300_QA5====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA5_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 50 dagen om 08:15 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 50 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Gebruiksduur
| |
− | |style="background-color: white;"|7 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|4 maal per dag 2 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Scenario 0.1 - MBH_300_QA6====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA6_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 5 dagen om 08:18 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 5 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 1 dag
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|3 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Bouwstenen ====
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgverlener identificatienummer
| |
− | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgegevens
| |
− | |style="background-color: white;"|Peter van Pulver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Specialisme
| |
− | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Zorgaanbieder
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgaanbieder identificatienummer
| |
− | |style="background-color: white;"|00001111 (in identificerend systeem: URA)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Organisatie naam
| |
− | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Adresgegevens
| |
− | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
| |
− | |}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v30-0-1 /><section end=mg-mp-mg-tst-MA-Scenarioset0-v30-0-1 />
| |
− | == TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)==
| |
− | <section begin=mg-mp-mg-tst-MA-Scenarioset0-v30-0-2 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset0-v30-0-2 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|B.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Blik
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999900389 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|13 okt 1963
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
| |
− | |}<section end=patient-mg-mp-mg-tst-MA-Scenarioset0-v30-0-2 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v30-0-2 />
| |
− | ==== Scenario 0.2 - MBH_300_QA1====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA1_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 20 dagen om 08:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 20 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 9 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|2 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Bouwstenen ====
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgverlener identificatienummer
| |
− | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgegevens
| |
− | |style="background-color: white;"|Peter van Pulver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Specialisme
| |
− | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Zorgaanbieder
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgaanbieder identificatienummer
| |
− | |style="background-color: white;"|00001111 (in identificerend systeem: URA)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Organisatie naam
| |
− | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Adresgegevens
| |
− | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
| |
− | |}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v30-0-2 /><section end=mg-mp-mg-tst-MA-Scenarioset0-v30-0-2 />
| |
− | == TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)==
| |
− | <section begin=mg-mp-mg-tst-MA-Scenarioset0-v30-0-3optioneel /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset0-v30-0-3optioneel />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|B.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Blik
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999900389 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|13 okt 1963
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
| |
− | |}<section end=patient-mg-mp-mg-tst-MA-Scenarioset0-v30-0-3optioneel /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v30-0-3optioneel />
| |
− | ==== Scenario 0.3 - MBH_300_QA4====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA4_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 10 dagen om 08:12 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 10 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 19 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Bouwstenen ====
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgverlener identificatienummer
| |
− | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgegevens
| |
− | |style="background-color: white;"|Peter van Pulver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Specialisme
| |
− | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Zorgaanbieder
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgaanbieder identificatienummer
| |
− | |style="background-color: white;"|00001111 (in identificerend systeem: URA)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Organisatie naam
| |
− | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Adresgegevens
| |
− | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
| |
− | |}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v30-0-3optioneel /><section end=mg-mp-mg-tst-MA-Scenarioset0-v30-0-3optioneel />
| |
− | == TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)==
| |
− | <section begin=mg-mp-mg-tst-MA-Scenarioset0-v30-0-4 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset0-v30-0-4 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|B.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Blik
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999900389 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|13 okt 1963
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
| |
− | |}<section end=patient-mg-mp-mg-tst-MA-Scenarioset0-v30-0-4 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v30-0-4 />
| |
− | ==== Scenario 0.4 - MBH_300_QA1====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA1_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 20 dagen om 08:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 20 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 9 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|2 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Scenario 0.4 - MBH_300_QA3====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA3_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 50 dagen om 08:10 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 50 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T - 11 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|2 maal per dag 50 ml
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Scenario 0.4 - MBH_300_QA4====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA4_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 10 dagen om 08:12 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 10 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 19 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Scenario 0.4 - MBH_300_QA6====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA6_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 5 dagen om 08:18 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 5 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 1 dag
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|3 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Bouwstenen ====
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgverlener identificatienummer
| |
− | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgegevens
| |
− | |style="background-color: white;"|Peter van Pulver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Specialisme
| |
− | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Zorgaanbieder
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgaanbieder identificatienummer
| |
− | |style="background-color: white;"|00001111 (in identificerend systeem: URA)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Organisatie naam
| |
− | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Adresgegevens
| |
− | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
| |
− | |}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v30-0-4 /><section end=mg-mp-mg-tst-MA-Scenarioset0-v30-0-4 />
| |
− | == TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)==
| |
− | <section begin=mg-mp-mg-tst-MA-Scenarioset0-v30-0-5 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset0-v30-0-5 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|B.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Blik
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999900389 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|13 okt 1963
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
| |
− | |}<section end=patient-mg-mp-mg-tst-MA-Scenarioset0-v30-0-5 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v30-0-5 />
| |
− | ==== Scenario 0.5 - MBH_300_QA2====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA2_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 100 dagen om 08:04 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 100 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T - 72 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 10 ml
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Scenario 0.5 - MBH_300_QA3====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA3_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 50 dagen om 08:10 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 50 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T - 11 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|2 maal per dag 50 ml
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Scenario 0.5 - MBH_300_QA5====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA5_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 50 dagen om 08:15 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 50 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Gebruiksduur
| |
− | |style="background-color: white;"|7 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|4 maal per dag 2 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Bouwstenen ====
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgverlener identificatienummer
| |
− | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgegevens
| |
− | |style="background-color: white;"|Peter van Pulver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Specialisme
| |
− | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Zorgaanbieder
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgaanbieder identificatienummer
| |
− | |style="background-color: white;"|00001111 (in identificerend systeem: URA)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Organisatie naam
| |
− | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Adresgegevens
| |
− | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
| |
− | |}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v30-0-5 /><section end=mg-mp-mg-tst-MA-Scenarioset0-v30-0-5 />
| |
− | == TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)==
| |
− | <section begin=mg-mp-mg-tst-MA-Scenarioset0-v30-0-6 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset0-v30-0-6 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|B.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Blik
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999900389 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|13 okt 1963
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
| |
− | |}<section end=patient-mg-mp-mg-tst-MA-Scenarioset0-v30-0-6 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v30-0-6 />
| |
− | ==== Scenario 0.6 - MBH_300_QA1====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA1_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 20 dagen om 08:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 20 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 9 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|2 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Scenario 0.6 - MBH_300_QA3====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA3_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 50 dagen om 08:10 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 50 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T - 11 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|2 maal per dag 50 ml
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Scenario 0.6 - MBH_300_QA4====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA4_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 10 dagen om 08:12 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 10 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 19 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Bouwstenen ====
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgverlener identificatienummer
| |
− | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgegevens
| |
− | |style="background-color: white;"|Peter van Pulver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Specialisme
| |
− | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Zorgaanbieder
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgaanbieder identificatienummer
| |
− | |style="background-color: white;"|00001111 (in identificerend systeem: URA)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Organisatie naam
| |
− | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Adresgegevens
| |
− | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
| |
− | |}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v30-0-6 /><section end=mg-mp-mg-tst-MA-Scenarioset0-v30-0-6 />
| |
− | == TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)==
| |
− | <section begin=mg-mp-mg-tst-MA-Scenarioset0-v30-0-7 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset0-v30-0-7 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|B.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Blik
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999900389 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|13 okt 1963
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
| |
− | |}<section end=patient-mg-mp-mg-tst-MA-Scenarioset0-v30-0-7 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v30-0-7 />
| |
− | ==== Scenario 0.7 - MBH_300_QA1====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_300_QA1_MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_300_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 20 dagen om 08:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 20 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 9 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|2 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | ==== Bouwstenen ====
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
| | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgverlener identificatienummer
| |
− | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgegevens
| |
− | |style="background-color: white;"|Peter van Pulver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Specialisme
| |
− | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Zorgaanbieder
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgaanbieder identificatienummer
| |
− | |style="background-color: white;"|00001111 (in identificerend systeem: URA)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Organisatie naam
| |
− | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Adresgegevens
| |
− | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
| |
− | |}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v30-0-7 /><section end=mg-mp-mg-tst-MA-Scenarioset0-v30-0-7 />
| |
− | == TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)==
| |
− | <section begin=mg-mp-mg-tst-MA-Scenarioset0-v30-0-8 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset0-v30-0-8 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
| | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|B.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Blik
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999900389 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|13 okt 1963
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
| |
− | |}<section end=patient-mg-mp-mg-tst-MA-Scenarioset0-v30-0-8 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v30-0-8 /><section end=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v30-0-8 /><section end=mg-mp-mg-tst-MA-Scenarioset0-v30-0-8 />
| |
| == TEST Medicatiegegevens MA Scenarioset 1== | | == TEST Medicatiegegevens MA Scenarioset 1== |
| <section begin=mg-mp-mg-tst-MA-Scenarioset1-v30-1-1 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset1-v30-1-1 /> | | <section begin=mg-mp-mg-tst-MA-Scenarioset1-v30-1-1 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset1-v30-1-1 /> |